Clinical Trials Directory

Trials / Completed

CompletedNCT00820989

Inflammation and the Host Response to Injury (In Healthy Volunteers)

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
116 (actual)
Sponsor
Rutgers, The State University of New Jersey · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

The body's immune response to injury or infection is very complex.Endotoxin is a man-made substance, which causes the body to "mimic" sickness (fever,chills, and achiness)for a few hours. This study is designed to determine whether certain proteins, genetics, or heart rate variability change affects the body's response to endotoxin.

Detailed description

The body's immune response to injury or infection is very complex.Immune cell activity, the release of specific mediators(such as proteins, genetics(Deoxyribonucleic acid or DNA), the body's "instructions" for making proteins (Ribonucleic Acid or RNA) and heart rate variability (HRV,the intervals between heartbeats) may affect the body's clinical response to stress such as infection.Endotoxin is a man-made substance, which causes the body to "mimic" sickness (fever,chills, and achiness)for a few hours. This study is designed to determine whether any of the above (proteins,genetics,or HRV, etc.) correlate with or affect the body's response to endotoxin.This will enable the investigator to better understand the mechanisms involved in the immune response as well as potential therapeutic strategies to improve outcomes in patients.

Conditions

Interventions

TypeNameDescription
BIOLOGICALEndotoxin, Lipopolysaccharide, LPSClinical Center Reference Endotoxin, lot 2, sterile saline, 2 ng/kg, bolus IV administration (\~5 minutes)

Timeline

Start date
2000-02-01
Primary completion
2011-02-01
Completion
2011-02-01
First posted
2009-01-12
Last updated
2014-05-21

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00820989. Inclusion in this directory is not an endorsement.